- Case Studies
- Technical Sheets
- Services Summaries
We are in the process of putting together our conference and exhibition schedule to the end of this year. So far we have a number of events on the horizon:
Event: The Chemistry of Collaboration 2016
Date: 6 October 2016
Venue: Oxford, UK
Event: ELRIG Drug Discovery 2016
Date: 13-14 October 2016
Venue: Liverpool, UK
Event: LATi 2016 Showcase: From Earth to Space and Beyond
Date: 24 October 2016
Venue: Loughborough University Science and Enterprise Park
Event: The 20th Anniversary UKASF
Date: 7-8 November 2016
Venue: The Imperial War Museum, Duxford, Cambridge, UK
Event: Antimocrobial Drug Discovery 2016: Plugging the Antibiotics Gap: A Medicinal Chemist’s Perspective
Date: 16 November 2016
Venue: Alderley Park, Manchester, UK
Should you wish to meet us at any of these events, please email us at:
As you may know, certainly if you were there, we held a draw on our stand across the three main days of EFMC in Manchester last week to win a range of Charnwood beers.
The winners of the specially selected “Charnwood Brewery” box sets are:
• François-René Alexandre of Idenix, France
• Francis Wilson of Summit, UK
• Hans-Peter Buchstaller of Merck, Germany
Pictured – François-René Alexandre with his prize on the Charnwood Molecular EFMC stand.
We look forward to seeing you at the next event/conference.
We are in attendance at next month’s Mastering Medicinal Chemistry conference, which takes place this year in Boston, MA, USA.
Charnwood Molecular’s, Business Development Director, Dr Robin Wilkes, will be at the event and should you wish to organise in advance to meet up with him, please email him directly at:
The Mastering Medicinal Chemistry conference is now in its 14th year and remains a well-established and popular annual event for senior-level medicinal chemists. The 2016 program features the hottest topics in medicinal chemistry from leaders in the pharmaceutical, biotech and academic spaces. Through cutting-edge case studies, panel discussions, poster presentations and breakout discussions, we showcase the biggest opportunities for small molecules. Several topics will be given special coverage, including small molecules in immuno-oncology, covalent inhibitors, receptor kinetics, CNS kinases, macrocycles, screening diversity, high-throughput experimentation, and novel targets such as RNA, and transporters.
We are exhibiting at the forthcoming XXIV EFMC International Symposium on Medicinal Chemistry.
Charnwood Molecular will be exhibiting on Stand 38 in the main exhibition area.
The event is held from 28th August to 1st September 2016 at the International Conference Centre, Manchester, UK.
EFMC is organised by the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry, on behalf of the European Federation for Medicinal Chemistry (EFMC).
More details on the event can be found here:
If you would like to visit us at the event, please email us at:
No stranger to the limelight, being the author of our “Views from the Bench – Chemist’s Blog”, Phil Thorne has been involved with the Scientific Laboratory Show’s new campaign to chronicle the ‘History of the Laboratory in Ten Objects’.
Phil points to the mass-production of laboratory glassware as a major turning point in the history of the laboratory.
The top ten nominated objects will go into the Show’s ‘Hall of Fame’ on 25th May, and delegates will be asked to vote for their Number One object during the Show and conference.
Further details are available here:
Our Business Development Director, Robin Wilkes, took a look at positive signs for the Drug Discovery industry earlier this year and assembled some of the reasons behind this in an article he put together for a number of news websites. It is reproduced here:-
Seems like we have only just started 2016 but already there’s positive signs in the news for how the Pharmaceutical industry is now addressing the discovery of new medicines…
1. There were 51 New Drug Approvals in 2015, a 66 year high, with nearly 40% of those being ‘first in class’ therapeutics and 60% being small molecules. Perhaps this shows increasing innovation levels in the industry including……
2. The delivery of new technologies such as 3D-printing, from which the first Drug Approval was granted by the FDA in 2015. Spritam® (levetiracetam), for the treatment of epileptic seizures, is the first drug to be manufactured with this technology. Innovation will be further driven by…
3. The availability of new molecular tools, such as CRISPR-Cas9, which edits genes and from which there are positive hopes for the delivery of new therapeutics. There also appears to have been a refocusing of where resources are deployed, for example….
4. The industry appears to have woken up to the important need for new Antibiotics, with new and fairer ways to pay for their development now on the agendas of both Pharma companies and Governments. And…
5. Pharma companies are now also focusing more on Rare or Orphan diseases, defined as those which affect <200K people in USA or <5 in 10K people in Europe. 2016 will see two drugs enter the market for such diseases that have the potential to become ‘blockbusters’, prompting interest beyond niche Biotech companies.
We are in the process of putting together our conference schedule for the next couple of months.
So far we have a couple of events on the horizon:
Event: 27th Symposium on Medicinal Chemistry in Eastern England
Date: 21 April 2016
Venue: Hatfield, UK
Event: Kinase 2016: Next Generation Inhibitors
Date: 16-17 May 2016
Venue: BioCity, Nottingham
Should you wish to meet us at either of these, please email us at: email@example.com
Charnwood Molecular will be exhibiting at Frontiers in Medicinal Chemistry in Bonn next week alongside Reach Separations. We look forward to meeting both existing collaborators and new clients.
Please visit us to pick up several new technical notes that we have available on our range of Synthetic Chemistry services for Drug Discovery programs.
The international symposium will focus on current developments, novel approaches and cutting-edge technologies in the field of medicinal chemistry and drug research with sessions on Target Identification & Lead Discovery, Allosteric Modulators & Modulation of Protein-Protein Interactions, Antibacterial Drugs, Structural Biology, and Highlights in Medicinal Chemistry and Technology. The scientific program will include plenary lectures, short lectures, and poster presentations. Furthermore, oral communications of (post)doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Medicinal Chemistry and related fields of research.
If you wish to meet at the event, please get in touch with Dr Sylvain Blanc by email at:
Charnwood Molecular is represented at the forthcoming Mastering MedChem symposium, with Dr David Lathbury speaking at the event.
The BMCS Mastering MedChem II: 2nd RSC-BMCS symposium on mastering medicinal chemistry takes place on 9 March 2016 in Huddersfield.
In the main there are two types of drug discovery programmes: those that hit serious problems and those that are going to hit serious problems. The difference between success and failure is how we, as medicinal chemists, tackle and resolve the problems.
If you would like further information, please email us at : firstname.lastname@example.org or visit: http://www.rsc.org/events/detail/19080/the-bmcs-mastering-medchem-ii-2nd-rsc-bmcs-symposium-on-mastering-medicinal-chemistry
We are attending the following events and conferences next month.
If you would like further information on our participation in any of the following events, or would like to arrange to meet one of our representatives at any of the venues, please contact us via email at:
Event: Mastering MedChem: 2nd RSC-BMCS Symposium
Date: 9 March 2016
Venue: University of Huddersfield
Event: Frontiers in Medicinal Chemistry
Date: 13-16 March 2016
Venue: Bonn, Germany
Event: 5th RSC/SCI Symposium on Ion channels as Therapeutic Targets
Date: 14-15 March 2016
Venue: Wellcome Genome Campus Conference Centre, Cambridge, UK
Event: Research & Innovation 2016
Date: 23 March 2016
Venue: Trent Vineyard, Nottingham